Home > Income Statement > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Revenue

    Back to Income Statement
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
AD     Remove this Ad

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹48,497 Cr₹43,886 Cr₹38,654 Cr₹33,498 Cr₹32,838 Cr

What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?

The latest Revenue ratio of SUN PHARMACEUTICAL INDUSTRIES is ₹48,497 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹48,497 Cr
Mar2024₹43,886 Cr
Mar2023₹38,654 Cr
Mar2022₹33,498 Cr
Mar2021₹32,838 Cr

How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years Revenue % Change
Mar2025 ₹48,497 Cr
10.51
Mar2024 ₹43,886 Cr
13.53
Mar2023 ₹38,654 Cr
15.39
Mar2022 ₹33,498 Cr
2.01
Mar2021 ₹32,838 Cr -

Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹413,747.3 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics
MANKIND PHARMA ₹83,688.0 Cr -2.6% -5.6% -15% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

1.5%

5.5%

0.5%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses